Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

StressGen commences phase II trial of HspE7 for treatment of cervical cancer

Sep. 12, 2000

Maxamine granted priority FDA review for melanoma

Sep. 8, 2000

Herceptin approved in E.U. for treatment of HER2-positive metastatic breast cancer

Aug. 30, 2000

Cancer vaccine shows potential for decreasing risk of relapse and death

Aug. 30, 2000

LifeTime Pharmaceuticals announces U.S. phase I/II trials of Beta LT for cancer

Aug. 29, 2000

Cel-Sci to commence phase II Multikine study in Czech Republic

Aug. 24, 2000

Ilex and Millennium respond to FDA letter on Campath

Aug. 24, 2000

Bioniche reports preclinical findings for MCC in prostate cancer

Aug. 21, 2000

Phytera and Novelos Therapeutics enter collaborative agreement for novel cancer immunotherapy

Aug. 18, 2000

Biomira initiates phase IIb trial of BLP25 vaccine

Aug. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...